|
|
|
| Anti-tumor mechanism of ketogenic diet |
| 1ZHANG Jie, 2YUAN Bao-hui, 1YU Wei-nan, 3MIAO Ming-yong |
| 1Department of Endocrinology, Affiliated Huai'an Hospital of Xuzhou Medical College, Huai'an 223002, Jiangsu, China; 2Laboratory of Clinical Nutrition, Liaocheng University, Liaocheng 252000, Shandong, China; 3Department of Biochemistry and Molecular Biology, The College of Basic Medical Sciences, The Second Military Medical University, Shanghai 200433, China |
|
|
|
|
Abstract KD was firstly applied to treat cerebral diseases, such as cerebral glioma, epilepsy and so on. Researches of last two decades found that chronic inflammation, elevated blood glucose were closely related to tumor development. Regular exercise and fasting could lower blood glucose, increase the concentration of plasma ketone bodies and reduce the inflammatory response. KD, characterized as high fat and very low carbohydrate could evoke a physiological state similar to exercise or fasting. These promote its possible use in treatment of metabolic diseases. With the intensive studies of metabolism and nutrition of cancer, there were growing evidences indicating cellular metabolism plays a very important role in the occurrence and development of tumor. With the application of various experimental methods and the breakthrough of signaling pathways, researchers believed altered metabolism of cancer cells is a potential target for therapeutic intervention. Thus, the anti-tumor effect of KD had become a research focus in recent years. Cancer cells depend on glucose as main energy, and the patients themselves need to consume more fat and protein, accordingly, the ketogenic theory providing enough protein and fat, limiting glucose can treat cancer theoretically. The KD making use of the characteristics of mitochondrial defects and glucose dependent of tumor cells, through suppressing inflammation, enhancing immune response, improving the ability of antioxidant stress, regulating related signal pathway, etc., inhibits tumor growth, improves patients’ quality of life, prolonges the survival of patients and enhances the sensitivity to radiotherapy and chemotherapy. These mechanisms provided a theoretical basis for the application of KD in cancer treatment. However, some mechanisms were not fully elucidated, further basic research and clinical trials is needed to confirm.
|
|
|
|
|
|
| [1] |
Huang Jing， Liu Li， Liu Lihui， Zhang Lin， Zhang Jie， He Ying， Liu Xiaoyan. The nutritional risk and the relation to length of hospital stay among patients with retroperitoneal tumor[J]. Electronic Journal of Metabolism and Nutrition of, 2020, 7(2): 178-182. |
| [2] |
Cui Jiuwei， Zhuo Wenlei， Huang Lan， Xu Chuan， Sun Xuejun， Liu Yudi， Tian Huimin， Liang Tingting， Chen Ping， Chen Bo， Liu Qiuyan， Ying Jie’er， Li Ningning， Zhang Anping， Yu Yang， Zhou Zhifeng， Wu Xiufe. Guideline on cancer immunonutrition[J]. Electronic Journal of Metabolism and Nutrition of, 2020, 7(2): 160-168. |
| [3] |
Liu Zuping， Bai Lian，Zeng Yonghong，Tang Ying，Lyu Yunli，Chen Xiaoyu. Analysis of nutritional status and postoperative infection in patients with gastrointestinal cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2020, 7(2): 183-187. |
| [4] |
Zhou Kun， Zheng Zunrong， Zhou Yuzhen. Correlation analysis of FA， VitB12， Fer， HCY and prognosis in patients with malignant tumor of digestive system[J]. Electronic Journal of Metabolism and Nutrition of, 2020, 7(2): 193-198. |
| [5] |
Zou Hongbo， Yan Xialin，Yu Dingye， Yu Zhen. Research progress on diagnosis and treatment of sarcopenia in tumor patients[J]. Electronic Journal of Metabolism and Nutrition of, 2020, 7(2): 250-254. |
| [6] |
Li Zengning， Li Xiaoling， Chen Wei， Qi Yumei， Hu Wen， Ge Sheng， Zhou Chunling， Yang Xuefeng， Zhang Pianhong， Lai Jianqiang， Jiao Guangyu， Hu Huaidong， Gao Shuqing， Wang Xiaolin， Zhang Yongsheng， Hu Xi. Expert consensus on appetite assessment and regulation in cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2020, 7(2): 169-177. |
|
|
|
|
